Cargando…

Effects of sleeve gastrectomy on insulin resistance

BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BP...

Descripción completa

Detalles Bibliográficos
Autores principales: CĂTOI, ADRIANA FLORINELA, PÂRVU, ALINA, MIRONIUC, AUREL, GALEA, ROMEO FLORIN, MUREŞAN, ADRIANA, BIDIAN, CRISTINA, POP, IOANA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849386/
https://www.ncbi.nlm.nih.gov/pubmed/27152079
http://dx.doi.org/10.15386/cjmed-576
_version_ 1782429532624519168
author CĂTOI, ADRIANA FLORINELA
PÂRVU, ALINA
MIRONIUC, AUREL
GALEA, ROMEO FLORIN
MUREŞAN, ADRIANA
BIDIAN, CRISTINA
POP, IOANA
author_facet CĂTOI, ADRIANA FLORINELA
PÂRVU, ALINA
MIRONIUC, AUREL
GALEA, ROMEO FLORIN
MUREŞAN, ADRIANA
BIDIAN, CRISTINA
POP, IOANA
author_sort CĂTOI, ADRIANA FLORINELA
collection PubMed
description BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BPD) leads to significant early reduction of insulinemia and of IR calculated through the homeostatic model assessment (HOMA-IR), independently of fat mass decrease. Sleeve gastrectomy (SG) is now used as a sole weight loss operation with good results. Therefore, the aim of the present study was to investigate the early changes of fasting blood glucose, insulin and HOMA-IR in a group of morbidly obese (MO) patients i.e. at 7, 30 and 90 days after SG. METHODS: The study included 20 MO patients (7 male and 13 female) submitted to SG. Anthropometrical (weight, body mass index –BMI, percent excess BMI loss -%EBMIL) and biochemical (plasma glucose, insulin and calculated HOMA-IR ) evaluation were performed before and at 7, 30 and 90 days after SG. In addition, a second group of 10 normal weight healthy subjects with a BMI ranging form 19 kg/m(2) to 23.14 kg/m(2), matched for age and gender was investigated. RESULTS: Plasma glucose (p=0.018), insulin (p=0.004) and HOMA-IR (p=0.006) values were statistically different between the studied groups. After surgery, at every follow-up point, there were statistically different weight and BMI mean values relative to the operation day (p<0.003). BMI, decreased at 7 days (estimated reduction=2.79; 95% CI:[2.12;3.45]), at 30 days (estimated reduction=5.65; 95% CI:[3.57;7.73]) and at 90 days (estimated reduction=10.88; 95% CI:[7.35;14.41]) respectively after SG. We noted a tendency toward statistical significant change of mean insulin values at 7 days after surgery (corrected p=0.075), no statistical change at 30 days (corrected p=0.327) and a significant change at 90 days (corrected p=0.027) after SG as compared to baseline. There was a significant change in mean values of HOMA-IR at 30 days (corrected p=0.009) and at 90 days (corrected p=0.021) after the operation day. CONCLUSIONS: The present study showed important early changes consisting in reductions of mean values of plasma insulin and HOMA-IR after SG.
format Online
Article
Text
id pubmed-4849386
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-48493862016-05-05 Effects of sleeve gastrectomy on insulin resistance CĂTOI, ADRIANA FLORINELA PÂRVU, ALINA MIRONIUC, AUREL GALEA, ROMEO FLORIN MUREŞAN, ADRIANA BIDIAN, CRISTINA POP, IOANA Clujul Med Original Research BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BPD) leads to significant early reduction of insulinemia and of IR calculated through the homeostatic model assessment (HOMA-IR), independently of fat mass decrease. Sleeve gastrectomy (SG) is now used as a sole weight loss operation with good results. Therefore, the aim of the present study was to investigate the early changes of fasting blood glucose, insulin and HOMA-IR in a group of morbidly obese (MO) patients i.e. at 7, 30 and 90 days after SG. METHODS: The study included 20 MO patients (7 male and 13 female) submitted to SG. Anthropometrical (weight, body mass index –BMI, percent excess BMI loss -%EBMIL) and biochemical (plasma glucose, insulin and calculated HOMA-IR ) evaluation were performed before and at 7, 30 and 90 days after SG. In addition, a second group of 10 normal weight healthy subjects with a BMI ranging form 19 kg/m(2) to 23.14 kg/m(2), matched for age and gender was investigated. RESULTS: Plasma glucose (p=0.018), insulin (p=0.004) and HOMA-IR (p=0.006) values were statistically different between the studied groups. After surgery, at every follow-up point, there were statistically different weight and BMI mean values relative to the operation day (p<0.003). BMI, decreased at 7 days (estimated reduction=2.79; 95% CI:[2.12;3.45]), at 30 days (estimated reduction=5.65; 95% CI:[3.57;7.73]) and at 90 days (estimated reduction=10.88; 95% CI:[7.35;14.41]) respectively after SG. We noted a tendency toward statistical significant change of mean insulin values at 7 days after surgery (corrected p=0.075), no statistical change at 30 days (corrected p=0.327) and a significant change at 90 days (corrected p=0.027) after SG as compared to baseline. There was a significant change in mean values of HOMA-IR at 30 days (corrected p=0.009) and at 90 days (corrected p=0.021) after the operation day. CONCLUSIONS: The present study showed important early changes consisting in reductions of mean values of plasma insulin and HOMA-IR after SG. Iuliu Hatieganu University of Medicine and Pharmacy 2016 2016-04-15 /pmc/articles/PMC4849386/ /pubmed/27152079 http://dx.doi.org/10.15386/cjmed-576 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Original Research
CĂTOI, ADRIANA FLORINELA
PÂRVU, ALINA
MIRONIUC, AUREL
GALEA, ROMEO FLORIN
MUREŞAN, ADRIANA
BIDIAN, CRISTINA
POP, IOANA
Effects of sleeve gastrectomy on insulin resistance
title Effects of sleeve gastrectomy on insulin resistance
title_full Effects of sleeve gastrectomy on insulin resistance
title_fullStr Effects of sleeve gastrectomy on insulin resistance
title_full_unstemmed Effects of sleeve gastrectomy on insulin resistance
title_short Effects of sleeve gastrectomy on insulin resistance
title_sort effects of sleeve gastrectomy on insulin resistance
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849386/
https://www.ncbi.nlm.nih.gov/pubmed/27152079
http://dx.doi.org/10.15386/cjmed-576
work_keys_str_mv AT catoiadrianaflorinela effectsofsleevegastrectomyoninsulinresistance
AT parvualina effectsofsleevegastrectomyoninsulinresistance
AT mironiucaurel effectsofsleevegastrectomyoninsulinresistance
AT galearomeoflorin effectsofsleevegastrectomyoninsulinresistance
AT muresanadriana effectsofsleevegastrectomyoninsulinresistance
AT bidiancristina effectsofsleevegastrectomyoninsulinresistance
AT popioana effectsofsleevegastrectomyoninsulinresistance